Table 1.
Baseline Sociodemographic and Clinical Characteristics (N=36)
| All participants (N=36) | Initial palliative care consultation only (n=7) | Palliative care consultation + follow-up (n=29) | Sig. | |
|---|---|---|---|---|
| Age, years (mean±SD) |
53.9±8.0 |
52.7±6.3 |
54.1±8.4 |
0.850 |
| Male, n (%) |
26 (72.2) |
4 (57.1) |
22 (75.9%) |
0.583 |
| Race, n (%) |
|
|
|
0.468 |
| Hispanic |
5 (13.9) |
1 (14.3) |
4 (13.8) |
|
| White |
22 (61.1) |
3 (42.9) |
19 (55.5) |
|
| Black |
9 (25.0) |
3 (42.9) |
6 (20.7) |
|
| Married, n (%) |
25 (69.4) |
6 (85.7) |
19 (65.5) |
0.578 |
| Education, n (%) |
|
|
|
0.824 |
| ≤High school graduate |
17 (47.2) |
3 (42.8) |
14 (48.3) |
|
| Some college |
10 (27.8) |
2 (28.6) |
8 (27.6) |
|
| ≥College graduate |
9 (25.0) |
2 (28.6) |
7 (24.1) |
|
| Ejection fraction, % (mean±SD) |
25.4±5.2 |
23.1±4.3 |
25.9±5.3 |
0.094 |
| Charlson Comorbidity Index (mean±SD) |
3.7±1.5 |
2.7±1.4 |
3.9±1.5 |
0.134 |
| NYHA class, N (%) |
|
|
|
0.983 |
| Class II |
25 (69.4) |
5 (71.4) |
20 (69.0) |
|
| Class III |
11 (30.6) |
2 (28.6) |
9 (31.0) |
|
| Comorbidities | ||||
| Hypertension, n (%) |
22 (61.1) |
3 (42.9) |
19 (65.5) |
0.523 |
| Coronary artery disease, n (%) |
22 (61.1) |
4 (57.1) |
18 (62.1) |
0.957 |
| Diabetes mellitus, type 2, n (%) |
12 (33.3) |
3 (42.9) |
9 (31.0) |
0.246 |
| Overweight or obese, n (%) |
25 (69.4) |
4 (57.1) |
21 (72.4) |
0.575 |
| History smoking (previous), n (%) |
14 (38.9) |
3 (42.8) |
11 (37.9) |
0.942 |
| Medications used, N (%) | ||||
| Ace inhibitors |
26 (72.2) |
5 (71.4) |
21 (72.4) |
0.847 |
| Angiotensin receptor blockers |
7 (19.4) |
2 (28.5) |
5 (17.2) |
|
| Beta-blockers |
26 (72.2) |
5 (71.4) |
21 (72.4) |
0.847 |
| Diuretics |
23 (63.9) |
5 (71.4) |
18 (62.1) |
0.578 |
| Pain medications |
11 (30.6) |
3 (42.9) |
8 (27.6) |
0.335 |
| Antidepressants | 8 (22.2) | 2 (28.6) | 6 (20.6) | 0.430 |
NYHA, New York Heart Association.